Date de publication: 18 mai 2009
Promoteur – Intermédiaire Financier
Orion OyjLieu
Description
The project covers Orion’s Research & Development activities in the period 2009 up to and including 2012. The focus of these activities is for projects that fall within Orion’s core areas of pharmaceutical expertise.
Objectifs
The project covers Orion’s Research & Development activities in the period 2009 up to and including 2012. The focus of these activities is for projects that fall within Orion’s core areas of pharmaceutical expertise.
Secteur(s)
Montant BEI envisagé (montant approximatif)
EUR 75 million.
Coût total (montant approximatif)
Over EUR 300 million.
Aspects environnementaux
The project involves activities that will be carried out within existing R&D facilities, making use of existing laboratories, pilot plants, clinical centres, etc. An EIA is therefore not required by the EIA Directive 85/337/EEC, amended by Directive 97/11/EC. The promoter’s R&D facilities comply with relevant EU and environmental legislation.
Passation des marchés
The R&D activities are mostly carried out by internal staff. The promoter carries out competitive enquiries among potential suppliers for goods and services. These procedures, which are typical for the industry, are in the best interests of the project and satisfactory to the Bank.
Statut
Signé - 22/12/2009
Clause de non-responsabilité
Avant d’être approuvés par le Conseil d’administration et avant la signature des prêts correspondants, les projets font l’objet d’une instruction et de négociations. Par conséquent, les informations et données fournies sur cette page sont indicatives.
Elles sont fournies à des fins de transparence uniquement et ne peuvent être considérées comme représentant la politique officielle de la BEI (voir également les notes explicatives).